Phone:
(701)814-6992
Physical address:
6296 Donnelly Plaza
Ratkeville, Bahamas.
Fibroscan 430 Mini + Price
FibroScan® 430 Mini/Mini+ is a class IIa medical device according to Rule 10 of ANNEX VIII of Regulation EU 2017/745 (CE 0459) and is manufactured by Echosens™. FibroScan® 430 Mini/Mini+ is intended to provide Liver stiffness measurements at a shear wave frequency of 50 Hz and Liver ultrasound attenuation measurements (CAP: Controlled Attenuation Parameter) at 3.5 MHz. FibroScan® 430 Mini/Mini+ is a non-invasive device intended to aid clinical management, diagnosis, and monitoring of patients with confirmed or suspected chronic liver disease, as part of an overall assessment of the liver. FibroScan® device may aid the healthcare professionals in the assessment of liver fibrosis, steatosis, and in determining the likelihood of cirrhosis. FibroScan® device is used, in conjunction with other clinical and laboratory data, during liver assessment in patients with confirmed or suspected chronic liver disease. Examinations with FibroScan® device shall be performed by an operator who has been certified by the manufacturer or its approved local representative. Operators are expressly recommended to carefully read the instructions given in the user manual and on the labelling of these products. Check cost defrayal conditions with paying bodies.
Click to add this item to cart.
Product Description
The FibroScan 430 Mini+ Price is an advanced, portable diagnostic device designed for the non-invasive assessment of liver health. It leverages state-of-the-art transient elastography technology to measure liver stiffness and Controlled Attenuation Parameter (CAP), offering comprehensive insights into liver fibrosis and steatosis. This device is particularly valued for its portability, making it suitable for a wide range of healthcare settings, including clinics, hospitals, and mobile diagnostics.
The mobile non-invasive solution for liver disease management, ideal for multi-site configuration. – COMPLETELY transportable table-top model – Packed in ORIGNAL SAMSONITE Trolley from France
1. European Association for Study of Liver, Association Latino Americana para el Studio del Higdon. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237-264. doi:10.1016/j.jhep.2015.04.006.
2. Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022-1030. doi:10.1016/j.jhep.2016.12.022.
3. Recio E, Cifuentes C, Macías J, et al. Interobserver concordance in controlled attenuation parameter measurement, a novel tool or the assessment of hepatic steatosis on the basis of transient elastography. Eur J Gastroenterol Hepatol. 2013;25(8):905-911.doi:10.1097/MEG.0b013e32835f4c3d.
FibroScan® Mini+ 430 or FibroScan® Mini 430: product name may differ depending on country.
